M.A. Lentz

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

Theo J. M. Ruers, Frits van Coevorden, Cornelis J.A. Punt et al. · JNCI Journal of the National Cancer Institute · 2017 · 678 citations · Full text

Medicine, Oncology, Surgery +17

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

Theo J. M. Ruers, Cornelis J.A. Punt, Frits van Coevorden et al. · Annals of Oncology · 2012 · 437 citations · Full text

Medicine, Oncology, Surgery +17

Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer

Pasquale F. Innominato, C. Focan, Thierry Gorlia et al. · Cancer Research · 2009 · 249 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

Sylvie Giacchetti, Georg A. Bjarnason, Carlo Garufi et al. · Journal of Clinical Oncology · 2006 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.

B Chevallier, P. Fumoleau, Pierre Kerbrat et al. · Journal of Clinical Oncology · 1995 · 223 citations

Medicine, Oncology, Pharmacology +16